Clinical Ink
Clinical Ink, Inc. specializes in providing eSource and patient engagement solutions designed to streamline clinical research for sites, sponsors, contract research organizations (CROs), and patients. Founded in 2006 and headquartered in Horsham, Pennsylvania, with additional offices in Winston-Salem and Cary, North Carolina, Philadelphia, Pennsylvania, and Cambridge, Massachusetts, the company offers a suite of innovative tools including SureSource, an electronic source platform that captures data and documents at the site level, and Lunexis ePRO+, which facilitates patient participation in studies. Additionally, Clinical Ink provides CentrosHealth, a patient engagement platform that includes configurable apps to enhance patient involvement and compliance throughout clinical trials. The company aims to improve clinical trial workflows by integrating electronic data capture and reducing manual processes, ensuring that clients have access to high-quality, validated data.
Top Stages
1 past transactions
Digital Artefacts
Acquisition in 2021
Digital Artefacts is a technology company that specializes in developing innovative solutions across various domains, including web and mobile applications, Internet of Things (IoT), wearable electronics, and virtual reality/augmented reality (VR/AR). The company also focuses on creating 3D modeling and time visualization software tailored for the healthcare industry. Their platform integrates cognitive, behavioral, and physiological data to facilitate decentralized clinical studies, which are crucial for researching autoimmune, oncology, and respiratory disorders through methodologies such as voice, movement, and mood analysis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.